NBEAL1
geneOn this page
Also known as MGC164581
Summary
NBEAL1 (neurobeachin like 1, HGNC:20681) is a protein-coding gene on chromosome 2q33.2, encoding Neurobeachin-like protein 1 (Q6ZS30).
Predicted to enable protein kinase binding activity. Predicted to be involved in protein localization. Predicted to be active in cytosol and membrane.
Source: NCBI Gene 65065 — RefSeq curated summary.
At a glance
- GWAS associations: 32
- Clinical variants (ClinVar): 406 total
- MANE Select transcript:
NM_001378026
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20681 |
| Approved symbol | NBEAL1 |
| Name | neurobeachin like 1 |
| Location | 2q33.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC164581 |
| Ensembl gene | ENSG00000144426 |
| Ensembl biotype | protein_coding |
| OMIM | 609816 |
| Entrez | 65065 |
Gene structure
Transcript identifiers
Ensembl transcripts: 24 — 8 protein_coding, 8 retained_intron, 4 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay
ENST00000414576, ENST00000434469, ENST00000449802, ENST00000460355, ENST00000460416, ENST00000463830, ENST00000478884, ENST00000483147, ENST00000492870, ENST00000497505, ENST00000681967, ENST00000682077, ENST00000682108, ENST00000682333, ENST00000682630, ENST00000682787, ENST00000683001, ENST00000683091, ENST00000683338, ENST00000683650, ENST00000683927, ENST00000683969, ENST00000684091, ENST00000684709
RefSeq mRNA: 2 — MANE Select: NM_001378026
NM_001114132, NM_001378026
CCDS: CCDS46495, CCDS92930
Canonical transcript exons
ENST00000683969 — 56 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001333887 | 203190292 | 203190389 |
| ENSE00001333892 | 203183279 | 203183388 |
| ENSE00001333895 | 203180382 | 203180512 |
| ENSE00001333898 | 203175147 | 203175287 |
| ENSE00001333904 | 203171928 | 203172023 |
| ENSE00001333910 | 203167227 | 203167360 |
| ENSE00001333914 | 203166149 | 203166297 |
| ENSE00001333916 | 203151465 | 203151589 |
| ENSE00001333920 | 203148991 | 203149148 |
| ENSE00001333921 | 203145011 | 203145160 |
| ENSE00001333924 | 203144600 | 203144905 |
| ENSE00001333926 | 203138162 | 203138315 |
| ENSE00001333928 | 203136599 | 203136774 |
| ENSE00001371491 | 203157699 | 203157825 |
| ENSE00001384936 | 203138620 | 203138748 |
| ENSE00001463745 | 203197302 | 203197391 |
| ENSE00001463746 | 203193795 | 203193911 |
| ENSE00001833013 | 203097547 | 203097633 |
| ENSE00002206568 | 203169747 | 203169851 |
| ENSE00002207261 | 203122254 | 203122343 |
| ENSE00002208676 | 203135677 | 203136252 |
| ENSE00002213757 | 203099629 | 203099712 |
| ENSE00002220041 | 203172729 | 203172853 |
| ENSE00002233100 | 203130318 | 203130476 |
| ENSE00002234428 | 203126824 | 203126926 |
| ENSE00002235744 | 203202687 | 203202781 |
| ENSE00002237033 | 203110150 | 203110282 |
| ENSE00002238831 | 203131973 | 203132132 |
| ENSE00002241658 | 203107608 | 203108188 |
| ENSE00002251991 | 203213518 | 203213653 |
| ENSE00002252461 | 203125352 | 203125520 |
| ENSE00002257897 | 203111979 | 203112098 |
| ENSE00002283824 | 203210958 | 203211106 |
| ENSE00002285606 | 203115985 | 203116070 |
| ENSE00002291371 | 203113015 | 203113318 |
| ENSE00002295183 | 203126557 | 203126716 |
| ENSE00002301628 | 203127781 | 203127937 |
| ENSE00002301936 | 203107420 | 203107518 |
| ENSE00002303782 | 203208637 | 203208753 |
| ENSE00002307696 | 203199338 | 203199447 |
| ENSE00002316189 | 203125960 | 203126093 |
| ENSE00002318888 | 203201543 | 203201715 |
| ENSE00002319087 | 203133058 | 203133146 |
| ENSE00002320798 | 203209161 | 203209322 |
| ENSE00003467861 | 203049814 | 203049975 |
| ENSE00003479507 | 203016156 | 203016435 |
| ENSE00003494024 | 203068393 | 203068475 |
| ENSE00003515927 | 203083219 | 203083525 |
| ENSE00003555821 | 203056427 | 203056508 |
| ENSE00003578053 | 203041765 | 203041856 |
| ENSE00003580418 | 203084463 | 203084569 |
| ENSE00003582717 | 203077752 | 203077837 |
| ENSE00003596600 | 203057326 | 203057453 |
| ENSE00003654468 | 203188472 | 203188589 |
| ENSE00003921189 | 203217253 | 203225194 |
| ENSE00003921521 | 203014875 | 203014982 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 93.78.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9706 / max 236.3705, expressed in 1797 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 24740 | 11.6213 | 1787 |
| 24741 | 2.5501 | 1285 |
| 24739 | 0.8334 | 284 |
| 24738 | 0.4886 | 173 |
| 202538 | 0.2834 | 80 |
| 24742 | 0.1938 | 58 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 93.78 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.17 | gold quality |
| cauda epididymis | UBERON:0004360 | 91.49 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.36 | gold quality |
| jejunal mucosa | UBERON:0000399 | 91.28 | gold quality |
| pylorus | UBERON:0001166 | 90.42 | gold quality |
| bone marrow cell | CL:0002092 | 90.13 | gold quality |
| caput epididymis | UBERON:0004358 | 89.88 | gold quality |
| corpus epididymis | UBERON:0004359 | 89.71 | gold quality |
| saphenous vein | UBERON:0007318 | 89.16 | gold quality |
| cardia of stomach | UBERON:0001162 | 88.69 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 88.18 | gold quality |
| pericardium | UBERON:0002407 | 87.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.00 | gold quality |
| tendon | UBERON:0000043 | 86.92 | gold quality |
| renal medulla | UBERON:0000362 | 86.02 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 85.86 | gold quality |
| adult organism | UBERON:0007023 | 85.70 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 85.43 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 84.11 | gold quality |
| nipple | UBERON:0002030 | 84.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.76 | gold quality |
| colonic mucosa | UBERON:0000317 | 83.56 | gold quality |
| jejunum | UBERON:0002115 | 83.53 | gold quality |
| cortical plate | UBERON:0005343 | 82.63 | gold quality |
| trachea | UBERON:0003126 | 82.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.38 | gold quality |
| oral cavity | UBERON:0000167 | 82.19 | gold quality |
| sural nerve | UBERON:0015488 | 82.19 | gold quality |
| corpus callosum | UBERON:0002336 | 82.02 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 13.61 |
| E-HCAD-35 | yes | 8.15 |
| E-CURD-135 | no | 1101.71 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
45 targeting NBEAL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-4645-3P | 99.76 | 69.33 | 993 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-3120-3P | 99.54 | 70.28 | 2669 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-130A-5P | 99.33 | 70.26 | 2623 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
Literature-anchored findings (GeneRIF, showing 1)
- isolation of human neurobeachin-like 1 (NBEAL1); highly expressed in the brain, kidney, prostate, and testis, and in biopsies of different grade glioma [NBEAL1] (PMID:15193433)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nbeal1 | ENSDARG00000099547 |
| mus_musculus | Nbeal1 | ENSMUSG00000073664 |
| rattus_norvegicus | Nbeal1 | ENSRNOG00000021525 |
| caenorhabditis_elegans | WBGENE00004760 | |
| caenorhabditis_elegans | WBGENE00007752 |
Paralogs (7): NSMAF (ENSG00000035681), WDFY4 (ENSG00000128815), LYST (ENSG00000143669), NBEAL2 (ENSG00000160796), WDFY3 (ENSG00000163625), NBEA (ENSG00000172915), LRBA (ENSG00000198589)
Protein
Protein identifiers
Neurobeachin-like protein 1 — Q6ZS30 (reviewed: Q6ZS30)
Alternative names: Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein
All UniProt accessions (12): Q6ZS30, A0A804HHU0, A0A804HI87, A0A804HIR8, A0A804HJ72, A0A804HJM0, A0A804HJX4, A0A804HKB6, A0A804HKC1, A0A804HKS6, H7BZA0, H7C3C8
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Highly expressed in brain, kidney, prostate and testis. Weakly expressed in ovary, small intestine, colon and peripheral blood leukocytes. May be correlative to several tumors, such as ovary serous adenocarcinoma and metastasis mammary gland carcinoma breast.
Similarity. Belongs to the WD repeat neurobeachin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZS30-2 | 2 | yes |
| Q6ZS30-1 | 1 |
RefSeq proteins (2): NP_001107604, NP_001364955* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000409 | BEACH_dom | Domain |
| IPR001680 | WD40_rpt | Repeat |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR023362 | PH-BEACH_dom | Domain |
| IPR031570 | NBEA/BDCP_DUF4704 | Domain |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR036372 | BEACH_dom_sf | Homologous_superfamily |
| IPR046851 | NBCH_WD40 | Domain |
| IPR050865 | BEACH_Domain | Family |
Pfam: PF02138, PF14844, PF15787, PF16057, PF20426
UniProt features (14 total): region of interest 3, domain 2, splice variant 2, sequence conflict 2, repeat 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZS30-F1 | 75.20 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 99 (showing top):
GCANCTGNY_MYOD_Q6, MILI_PSEUDOPODIA_CHEMOTAXIS_UP, CUI_TCF21_TARGETS_2_DN, AACTGGA_MIR145, THUM_SYSTOLIC_HEART_FAILURE_DN, COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN, JOHNSTONE_PARVB_TARGETS_3_DN, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, MYC_UP.V1_DN, SRC_UP.V1_DN, STK33_SKM_UP, STK33_UP, GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN
GO Biological Process (1): intracellular protein localization (GO:0008104)
GO Molecular Function (2): protein kinase binding (GO:0019901), protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| macromolecule localization | 1 |
| kinase binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
580 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NBEAL1 | ICA1L | Q8NDH6 | 693 |
| NBEAL1 | FAM117B | Q6P1L5 | 652 |
| NBEAL1 | WDR12 | Q9GZL7 | 518 |
| NBEAL1 | ZBTB44 | Q8NCP5 | 472 |
| NBEAL1 | CARF | Q8N187 | 456 |
| NBEAL1 | A0A087WT04 | A0A087WT04 | 448 |
| NBEAL1 | C1QL1 | O75973 | 447 |
| NBEAL1 | SERTAD4 | Q9NUC0 | 446 |
| NBEAL1 | TRIM65 | Q6PJ69 | 437 |
| NBEAL1 | SLC25A44 | Q96H78 | 430 |
| NBEAL1 | MRPL38 | Q96DV4 | 423 |
| NBEAL1 | SACS | Q9NZJ4 | 422 |
| NBEAL1 | TRIM47 | Q96LD4 | 419 |
| NBEAL1 | C16orf95 | Q9H693 | 418 |
| NBEAL1 | SH3PXD2A | Q5TCZ1 | 405 |
IntAct
30 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SDC2 | PDPK1 | psi-mi:“MI:0914”(association) | 0.640 |
| ANKRD22 | ESYT2 | psi-mi:“MI:0914”(association) | 0.530 |
| ILVBL | SLC33A1 | psi-mi:“MI:0914”(association) | 0.530 |
| Nek9 | EML1 | psi-mi:“MI:0914”(association) | 0.350 |
| AP1S2 | SLC43A3 | psi-mi:“MI:0914”(association) | 0.350 |
| RGMA | BDP1 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPA1 | MATR3 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPU | psi-mi:“MI:0914”(association) | 0.350 | |
| Klc2 | KLC1 | psi-mi:“MI:0914”(association) | 0.350 |
| Smc1a | PDS5B | psi-mi:“MI:0914”(association) | 0.350 |
| HIF1A | PIAS1 | psi-mi:“MI:0914”(association) | 0.350 |
| KIF1C | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| Spire2 | KLF4 | psi-mi:“MI:0914”(association) | 0.350 |
| CHMP4B | psi-mi:“MI:0914”(association) | 0.350 | |
| CNTROB | CENPX | psi-mi:“MI:0914”(association) | 0.350 |
| SDC2 | METTL8 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| VPS35 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| NPTN | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| KCNE3 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| CD40 | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
| DHCR24 | PDE2A | psi-mi:“MI:0914”(association) | 0.350 |
| NPTN | RIMOC1 | psi-mi:“MI:0914”(association) | 0.350 |
| S1PR3 | STXBP3 | psi-mi:“MI:0914”(association) | 0.350 |
| VSIG1 | RIMOC1 | psi-mi:“MI:0914”(association) | 0.350 |
| MFSD14A | FAM171A2 | psi-mi:“MI:0914”(association) | 0.350 |
| NBEAL1 | hflK | psi-mi:“MI:0915”(physical association) | 0.000 |
| NBEAL1 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| NBEAL1 | cobB | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (35): NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-MS), NBEAL1 (Affinity Capture-RNA), NBEAL1 (Proximity Label-MS)
ESM2 similar proteins: A0JM23, A0M8T3, A1X154, A6H7D1, A7MBF6, A8Y5U1, B1WC10, E9Q9R9, F1M649, F1MHT9, O00750, O88480, O95876, P0CI65, P50851, Q008S8, Q00PJ3, Q07E17, Q07E30, Q07E43, Q09YN0, Q108U1, Q15052, Q2IBF5, Q2IBG0, Q2QLA4, Q2QLB5, Q32NR4, Q32NR9, Q3UP24, Q3V129, Q4V7F0, Q5XXR3, Q5ZLR6, Q692V3, Q6AZT7, Q6P2S7, Q6P3V7, Q6PIY5, Q6ZS30
Diamond homologs: A1C7E4, A5D7H2, D5GBI7, G4MQX3, O43815, O54927, O55106, P47025, P49026, P58404, P58405, P70483, P93340, P97499, Q00659, Q05040, Q13033, Q499N3, Q4VBE8, Q54J37, Q54TD8, Q5U2W5, Q68FJ6, Q6ZS30, Q7T2F6, Q8C4J7, Q99973, Q9C270, Q9ERG2, Q9NRL3, Q9Y6I7, A8XSV3, D4A929, E7FAW3, E9Q2M9, F4HZB2, F4IG73, F4JD14, F4JHT3, O35242
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
406 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 336 |
| Likely benign | 19 |
| Benign | 8 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
9340 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:203014983:G:GG | donor_gain | 1.0000 |
| 2:203016151:CACA:C | acceptor_loss | 1.0000 |
| 2:203016153:CA:C | acceptor_loss | 1.0000 |
| 2:203016154:A:C | acceptor_loss | 1.0000 |
| 2:203016155:GATTT:G | acceptor_gain | 1.0000 |
| 2:203041759:TTTCA:T | acceptor_loss | 1.0000 |
| 2:203041761:TCA:T | acceptor_loss | 1.0000 |
| 2:203041762:CAG:C | acceptor_loss | 1.0000 |
| 2:203041763:A:AG | acceptor_gain | 1.0000 |
| 2:203041763:AG:A | acceptor_loss | 1.0000 |
| 2:203041764:G:A | acceptor_loss | 1.0000 |
| 2:203041764:G:GG | acceptor_gain | 1.0000 |
| 2:203041764:GAA:G | acceptor_gain | 1.0000 |
| 2:203041764:GAAA:G | acceptor_gain | 1.0000 |
| 2:203041852:ACCAG:A | donor_loss | 1.0000 |
| 2:203041853:CCAG:C | donor_loss | 1.0000 |
| 2:203041854:CAGGT:C | donor_loss | 1.0000 |
| 2:203041855:AGGT:A | donor_loss | 1.0000 |
| 2:203041856:GGTA:G | donor_loss | 1.0000 |
| 2:203041857:G:A | donor_loss | 1.0000 |
| 2:203041858:T:A | donor_loss | 1.0000 |
| 2:203049951:TC:T | donor_gain | 1.0000 |
| 2:203056505:GCAA:G | donor_gain | 1.0000 |
| 2:203056509:G:GG | donor_gain | 1.0000 |
| 2:203057324:A:AG | acceptor_gain | 1.0000 |
| 2:203057325:G:GA | acceptor_gain | 1.0000 |
| 2:203057325:GTT:G | acceptor_gain | 1.0000 |
| 2:203057325:GTTA:G | acceptor_gain | 1.0000 |
| 2:203057325:GTTAA:G | acceptor_gain | 1.0000 |
| 2:203057452:GG:G | donor_gain | 1.0000 |
AlphaMissense
18009 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:203171931:T:A | W2007R | 1.000 |
| 2:203171931:T:C | W2007R | 1.000 |
| 2:203016415:T:A | W11R | 0.999 |
| 2:203016415:T:C | W11R | 0.999 |
| 2:203041789:T:A | W26R | 0.999 |
| 2:203041789:T:C | W26R | 0.999 |
| 2:203057434:T:A | W166R | 0.999 |
| 2:203057434:T:C | W166R | 0.999 |
| 2:203108085:T:A | W587R | 0.999 |
| 2:203108085:T:C | W587R | 0.999 |
| 2:203108174:G:C | R616S | 0.999 |
| 2:203108174:G:T | R616S | 0.999 |
| 2:203110181:G:C | A632P | 0.999 |
| 2:203113222:T:A | W775R | 0.999 |
| 2:203113222:T:C | W775R | 0.999 |
| 2:203171933:G:C | W2007C | 0.999 |
| 2:203171933:G:T | W2007C | 0.999 |
| 2:203171965:T:C | L2018P | 0.999 |
| 2:203171992:G:C | R2027P | 0.999 |
| 2:203172735:T:A | W2040R | 0.999 |
| 2:203172735:T:C | W2040R | 0.999 |
| 2:203183341:T:A | W2191R | 0.999 |
| 2:203183341:T:C | W2191R | 0.999 |
| 2:203188505:T:A | W2218R | 0.999 |
| 2:203188505:T:C | W2218R | 0.999 |
| 2:203199377:T:A | W2361R | 0.999 |
| 2:203199377:T:C | W2361R | 0.999 |
| 2:203077809:T:C | L219P | 0.998 |
| 2:203077815:G:A | G221E | 0.998 |
| 2:203084505:T:C | L345P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000003364 (2:203218113 C>A,T), RS1000015097 (2:203169953 C>T), RS1000029369 (2:203191129 G>A), RS1000057771 (2:203090546 A>G), RS1000061903 (2:203043949 C>G,T), RS1000062484 (2:203122158 A>G), RS1000081882 (2:203116440 A>T), RS1000119670 (2:203203180 T>C), RS1000143143 (2:203069978 A>G), RS1000172274 (2:203203480 CTG>C), RS1000175928 (2:203163296 G>T), RS1000186357 (2:203083966 T>C), RS1000200635 (2:203014428 T>G), RS1000229634 (2:203145533 C>T), RS1000270192 (2:203155697 C>T)
Disease associations
OMIM: gene MIM:609816 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
32 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_197 | Obesity-related traits | 3.000000e-06 |
| GCST001762_242 | Obesity-related traits | 4.000000e-07 |
| GCST001762_762 | Obesity-related traits | 2.000000e-07 |
| GCST001762_782 | Obesity-related traits | 2.000000e-07 |
| GCST003013_22 | White matter hyperintensity burden | 5.000000e-08 |
| GCST003013_8 | White matter hyperintensity burden | 6.000000e-08 |
| GCST005194_24 | Coronary artery disease | 2.000000e-32 |
| GCST005195_132 | Coronary artery disease | 1.000000e-32 |
| GCST005196_213 | Coronary artery disease | 2.000000e-32 |
| GCST007269_79 | Pulse pressure | 4.000000e-13 |
| GCST008876_38 | Non-lobar intracerebral hemorrhage (MTAG) | 2.000000e-07 |
| GCST008876_39 | Non-lobar intracerebral hemorrhage (MTAG) | 2.000000e-07 |
| GCST010101_5 | White matter hyperintensities | 4.000000e-13 |
| GCST010102_1 | White matter integrity (fractional anisotropy) | 7.000000e-08 |
| GCST010102_2 | White matter integrity (fractional anisotropy) | 6.000000e-09 |
| GCST010396_12 | Gut microbiota (bacterial taxa, hurdle binary method) | 9.000000e-06 |
| GCST010698_18 | Subcortical volume (min-P) | 1.000000e-08 |
| GCST010699_69 | Brain morphology (min-P) | 9.000000e-20 |
| GCST010700_6 | Cortical thickness (MOSTest) | 2.000000e-14 |
| GCST010701_36 | Cortical surface area (MOSTest) | 2.000000e-24 |
| GCST010702_146 | Subcortical volume (MOSTest) | 2.000000e-13 |
| GCST010703_42 | Brain morphology (MOSTest) | 1.000000e-08 |
| GCST010726_17 | Periventricular white matter hyperintensities | 1.000000e-09 |
| GCST011946_34 | White matter hyperintensity volume | 7.000000e-13 |
| GCST011949_4 | White matter hyperintensity volume (adjusted for hypertension) | 1.000000e-12 |
| GCST011952_7 | White matter hyperintensity volume x hypertension interaction (2df) | 5.000000e-12 |
| GCST012580_2 | White matter hyperintensities | 6.000000e-09 |
| GCST90000582_10 | Spontaneous coronary artery dissection | 2.000000e-06 |
| GCST90000582_11 | Spontaneous coronary artery dissection | 9.000000e-06 |
| GCST90002397_458 | Mean spheric corpuscular volume | 1.000000e-12 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004338 | body weight |
| EFO:0005106 | body composition measurement |
| EFO:0005665 | white matter hyperintensity measurement |
| EFO:0005763 | pulse pressure measurement |
| EFO:0010178 | non-lobar intracerebral hemorrhage |
| EFO:0004641 | white matter integrity |
| EFO:0007874 | gut microbiome measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, affects expression | 3 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance, increases expression | 2 |
| Arsenic | affects cotreatment, decreases expression, increases abundance, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | decreases reaction, affects binding | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | decreases expression | 1 |
| Caffeine | affects phosphorylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Coumestrol | affects cotreatment, decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Manganese | decreases expression, increases abundance, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Dronabinol | increases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TA03 | HAP1 NBEAL1 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder, stroke disorder